Retrospective evaluation of tiagabine overdose

Clinical Toxicology

Volumn 43, Issue 7, 2005, Pages 855-859

  Spiller, Henry ^a   Winter, Mark ^b   Ryan, Mark ^c   Krenzelok, Edward ^d   Anderson, Debra ^e   Thompson, Michael ^f   Kumar, Suparna ^g  

^a KENTUCKY REGIONAL POISON CENTER   (United States)

^b Southeast Texas Poison Center   (United States)

^c Louisiana Poison Control Center   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e Hennepin Regional Poison Center   (United States)

^f Missouri Regional Poison Center   (United States)

^g Tennessee Poison Center   (United States)

Author keywords

Overdose; Poison Center; Seizures; Tiagabine

Indexed keywords

ACTIVATED CARBON; BENZODIAZEPINE; DIPHENHYDRAMINE; DOPAMINE; GABATRIL; PHENOBARBITAL; PHENYTOIN; TIAGABINE; ANTICONVULSIVE AGENT; NIPECOTIC ACID DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL VENTILATION; BODY POSTURE; CHILD; CLINICAL FEATURE; COMA; CONFUSION; CONTROLLED STUDY; DIZZINESS; DRUG DOSE REGIMEN; DRUG OVERDOSE; DYSTONIA; EPILEPSY; EPILEPTIC STATE; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; HYPERTENSION; HYPOTENSION; LETHARGY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RESPIRATION DEPRESSION; RESTLESSNESS; SEIZURE; TACHYCARDIA; TIME; TREATMENT OUTCOME; TREMOR; DOSE RESPONSE; INTOXICATION; POISON CENTER; RETROSPECTIVE STUDY; REVIEW;

ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NIPECOTIC ACIDS; OVERDOSE; POISON CONTROL CENTERS; RETROSPECTIVE STUDIES;

EID: 33644833742     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650500357529     Document Type: Article

References (16)

1. Sills GJ, Butler E, Thompson GG, Brodie MJ. Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study. Seizure 1999; 8:404-411.
2. Leppik IE, Gram L, Deaton R, Sommerville KW. Safety of tiagabine: summary of 53 trials. Epilepsy Res 1999; 33:235-246.
3. Leach JP, Stolarek I, Brodie MJ. Deliberate overdose with the novel anticovulsant tiagabine. Seizure 1995; 4:155-157.
4. Viner K, Clifton HJC, Hryhorczuk DO, Paloueck FP, Williams RH, Fischbein CB. Status epilepticus following acute tiagabine overdose. (Abstract). J Toxicol Clin Toxicol 1999; 37:638.
5. Ostrovsky D, Spanaki MV, Morris GL. Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 2002; 43:773-774.
6. Kellinghaus C, Dziewas R, Ludermann P. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 2002; 11:243-249.
7. Trinka E, Moroder T, Nagler M, Staffen W, Loscher W, Ladurner G. Clinical and EEG findings in complex partial status epilepticus with tiagabine. Seizure 1999; 8:41-44.
8. Zhu Y, Vaughn BV. Non-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizure. Seizure 2002; 11:57-59.
9. Mangano S, Cusumano L, Fontana A. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient. Brain Dev 2003; 27:518-521.
10. Skodda S, Kramer I, Spittler JF, Gehlen W. Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment. J Neurol 2001; 248:109-112.
11. Balslev T, Uldall P, Buchholt J. Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients. Eur J Pediatr Neurol 2000; 4:169-170.
12. Brouns R, Van Paesschen W. Recurrent complex partial status epilepticus associated with tiagabine rechallenge. Acta Neurol Belg 2002; 102:19-20.
13. Piccinelli P, Borgatti R, Perucca E, Tofani A, Donati G, Balottin U. Frontal non-convulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria. Epilepsia 2000; 41:1485-1488.
14. Cantrell FL, Ritter M, Himes E. Intentional overdose with tiagabine: an unusual clinical presentation. J Emerg Med 2004; 27:271-272.
15. Gustavson LE, Mengel HB. Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses. Epilepsia 1995; 36(6):605-611.
16. Lau AH, Gustavson LE, Sperelakis R, Lam NP, El-Shourbagy T, Qian JX, Layden T. Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function. Epilepsia 1997; 38(4):445-451.